(2S,5S,8S,11R,14S,17S,20S,23S,26S,31S)-14,20,26-tris(4-aminobutyl)-11-((4-(3-benzoylbenzyloxy)-3-methylbut-2-enylthio)methyl)-5-sec-butyl-31-(4-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethylamino)butyl)-8-(4-(3,5-dinitrophenylamino)butyl)-17-((R)-1-hydroxyethyl)-23-(hydroxymethyl)-2-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,30,33,36,49-tridecaoxo-53-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-39,42,45,48-tetraoxa-3,6,9,12,15,18,21,24,27,29,32,37-dodecaazatripentacontan-1-oic acid

ID: ALA1253600

Chembl Id: CHEMBL1253600

PubChem CID: 52948480

Max Phase: Preclinical

Molecular Formula: C108H165N21O30S3

Molecular Weight: 2333.83

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCNc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)NC(=O)[C@H](CSC/C=C(\C)COCc1cccc(C(=O)c2ccccc2)c1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)NC(=O)[C@H](CCCCNC(C)=C1C(=O)CC(C)(C)CC1=O)NC(=O)CCC(=O)NCOCCOCCOCCOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)O

Standard InChI:  InChI=1S/C108H165N21O30S3/c1-9-67(3)92(103(145)119-81(105(147)148)40-52-160-8)124-98(140)79(34-19-24-45-113-73-55-74(128(151)152)57-75(56-73)129(153)154)117-102(144)84(63-161-53-39-66(2)61-158-62-70-26-25-29-72(54-70)95(137)71-27-11-10-12-28-71)121-96(138)77(30-15-20-41-109)118-104(146)93(69(5)131)125-99(141)78(31-16-21-42-110)116-101(143)82(60-130)120-97(139)80(32-17-22-43-111)122-107(150)127-100(142)76(33-18-23-44-112-68(4)91-85(132)58-108(6,7)59-86(91)133)115-89(135)38-37-88(134)114-65-157-49-48-155-46-47-156-50-51-159-90(136)36-14-13-35-87-94-83(64-162-87)123-106(149)126-94/h10-12,25-29,39,54-57,67,69,76-84,87,92-94,112-113,130-131H,9,13-24,30-38,40-53,58-65,109-111H2,1-8H3,(H,114,134)(H,115,135)(H,116,143)(H,117,144)(H,118,146)(H,119,145)(H,120,139)(H,121,138)(H,124,140)(H,125,141)(H,147,148)(H2,123,126,149)(H2,122,127,142,150)/b66-39+/t67-,69+,76-,77-,78-,79-,80-,81-,82-,83-,84-,87-,92-,93-,94-/m0/s1

Standard InChI Key:  HWZCGTRERFKDMG-KUXOGVNGSA-N

Associated Targets(non-human)

RCE1 CAAX prenyl protease 2 (349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 2333.83Molecular Weight (Monoisotopic): 2332.1193AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Kyro K, Manandhar SP, Mullen D, Schmidt WK, Distefano MD..  (2010)  Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate.,  18  (15): [PMID:20619662] [10.1016/j.bmc.2010.06.024]

Source